You are currently logged into
Hep Directory - My Account or Log Out

Home
Basics
News
- News
- Newsfeed
- Science News
- Features
- Conferences
- Hep Stories
- Hep Slideshows
- Hep TV
- By Author
- RSS Links
Hot Topics
Magazine
Blogs
Community
- Community
- Hep Stories
- Hep Forums
- Polls
- Surveys
- Ask Hep
- Services Directory
- Calendar
- Bookstore
About Us
- About Us
- About Us
- Masthead
- Awards
- Advertise
- Contact Us
Facebook
Twitter

© 2023 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Twitter

Facebook

Tumblr

#obeticholic acid

Experts Advise Against Approval of Obeticholic Acid for NASH

An FDA advisory committee expressed concerns about the safety of the fatty liver disease treatment.

Intercept NASH Drug OCA Gets FDA Fast-Track Status

The drug has been shown to help reduce markers of liver inflammation and fibrosis, as well as increase insulin sensitivity.

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.